The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma

Chimeric antigen receptor T (CAR T) cell therapy has demonstrated efficacy in the treatment of haematologic malignancies. However, the accompanying adverse events, the most common of which is cytokine release syndrome (CRS), substantially limit its wide application. Due to its unique physiological c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jianshu, Liu, Yang, Wang, Chunmeng, Zhang, Yajing, Tong, Chuan, Dai, Guanghai, Wang, Wei, Rasko, John E. J., Melenhorst, J. Joseph, Qian, Wenbin, Liang, Aibin, Han, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388484/
https://www.ncbi.nlm.nih.gov/pubmed/32728035
http://dx.doi.org/10.1038/s41392-020-00256-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388484/
https://www.ncbi.nlm.nih.gov/pubmed/32728035
http://dx.doi.org/10.1038/s41392-020-00256-x

Ejemplares similares